AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 192 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $210,000 | -75.4% | 6,400 | -61.2% | 0.00% | -50.0% |
| Q1 2021 | $852,000 | -36.3% | 16,500 | -56.8% | 0.00% | -50.0% |
| Q3 2020 | $1,337,000 | -20.2% | 38,200 | +8.8% | 0.00% | 0.0% |
| Q4 2019 | $1,676,000 | +523.0% | 35,100 | +550.0% | 0.00% | +300.0% |
| Q2 2019 | $269,000 | -82.9% | 5,400 | -84.2% | 0.00% | -75.0% |
| Q4 2018 | $1,577,000 | -24.0% | 34,200 | +27.1% | 0.00% | -20.0% |
| Q3 2018 | $2,075,000 | -65.0% | 26,900 | -61.8% | 0.01% | -68.8% |
| Q2 2018 | $5,930,000 | -21.4% | 70,400 | -23.7% | 0.02% | -20.0% |
| Q1 2018 | $7,548,000 | +23.6% | 92,300 | -13.6% | 0.02% | +25.0% |
| Q4 2017 | $6,106,000 | +114.7% | 106,800 | +150.7% | 0.02% | +100.0% |
| Q3 2017 | $2,844,000 | +30.4% | 42,600 | +0.5% | 0.01% | +14.3% |
| Q2 2017 | $2,181,000 | +0.4% | 42,400 | +14.0% | 0.01% | 0.0% |
| Q1 2017 | $2,172,000 | +61.1% | 37,200 | +15.2% | 0.01% | +40.0% |
| Q4 2016 | $1,348,000 | +82.4% | 32,300 | +130.7% | 0.01% | +66.7% |
| Q3 2016 | $739,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
| Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
| BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
| Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
| Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
| Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
| Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
| Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
| CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
| Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |